Aileron Therapeutics Inc (ALRN) has released an update.
Aileron Therapeutics, Inc. plans to conduct its 2023 annual stockholders’ meeting on February 28, 2024. The company, having skipped its meeting in 2023, has established January 29, 2024, as the deadline for receiving stockholder proposals for inclusion in the proxy materials. Proposals must adhere to the company’s Bylaws and SEC rules, with submissions to be sent to the company’s principal executive offices in Waltham, Massachusetts. Additionally, nominations for directors or other matters to be considered must arrive by February 8, 2024, and comply with the Bylaws and applicable laws.
For further insights into ALRN stock, check out TipRanks’ Stock Analysis page.
